Cargando…
Liposomal Dendritic Cell Vaccine in Breast Cancer Immunotherapy
[Image: see text] Cancer vaccine is well recognized as a promising approach for immunotherapy of cancers. Since dendritic cells (DCs) are capable of processing and presenting antigens to initiate the immune response cascade, the development of DC vaccines is considered as a good choice for the treat...
Autores principales: | Pan, Hong, Shi, Hongyan, Fu, Peng, Shi, Pengfei, Yang, Jianyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876850/ https://www.ncbi.nlm.nih.gov/pubmed/33585776 http://dx.doi.org/10.1021/acsomega.0c05924 |
Ejemplares similares
-
Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes
por: Sayour, Elias J., et al.
Publicado: (2018) -
Therapeutic Liposomal Vaccines for Dendritic Cell Activation or Tolerance
por: Nagy, Noémi Anna, et al.
Publicado: (2021) -
Engineering dendritic cell vaccines to improve cancer immunotherapy
por: Perez, Caleb R., et al.
Publicado: (2019) -
Research progress on dendritic cell vaccines in cancer immunotherapy
por: Yu, Jifeng, et al.
Publicado: (2022) -
Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
por: Shi, Chen, et al.
Publicado: (2023)